Adherence to adjuvant hormonal therapy in localised breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adherence to adjuvant hormonal therapy in localised breast cancer

Published:2022-10-07 Issue:6 Volume:31 Page:
ISSN:0961-5423
Container-title:European Journal of Cancer Care
language:en
Short-container-title:European J Cancer Care

Author:

Davies Steven¹,Voutsadakis Ioannis A.²³^ORCID

Affiliation:

1. Northern Ontario School of Medicine Sudbury Ontario Canada

2. Algoma District Cancer Program Sault Area Hospital Sault Ste. Marie Ontario Canada

3. Section of Internal Medicine, Division of Clinical Sciences Northern Ontario School of Medicine Sudbury Ontario Canada

Publisher

Hindawi Limited

Subject

Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ecc.13729

Reference29 articles.

1. Adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review and meta-synthesis of the qualitative literature using grounded theory

2. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

3. A nested case–control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage I–III breast cancer

4. A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer

5. Can demographic, clinical and treatment-related factors available at hormonal therapy initiation predict non-persistence in women with stage I–III breast cancer?

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast Conservation Project: Clinical Outcomes of Extreme Oncoplastic Breast-Conserving Therapy Versus Mastectomy for Large and Multiple Lesions;Annals of Surgical Oncology;2024-07-24

2. Arthralgia and myalgia associated with aromatase inhibitors: frequency and characterization in real-life patients;ecancermedicalscience;2024-04-16

3. Combination Therapy of Lox Inhibitor and Stimuli‐Responsive Drug for Mechanochemically Synergistic Breast Cancer Treatment;Advanced Healthcare Materials;2023-05-11

4. Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients;Current Oncology;2023-01-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3